메뉴 건너뛰기




Volumn 15, Issue 1, 1998, Pages 88-93

Selections from current literature: Pharmacological treatment of obesity

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIGENIC AGENT; FENFLURAMINE; PHENTERMINE; SEROTONIN UPTAKE INHIBITOR;

EID: 0031989159     PISSN: 02632136     EISSN: None     Source Type: Journal    
DOI: 10.1093/fampra/15.1.88     Document Type: Article
Times cited : (2)

References (21)
  • 1
    • 0026517115 scopus 로고
    • Long-term weight control: The National Heart, Lung, and Blood Institute funded multimodal intervention study
    • Weintraub M. Long-term weight control: the National Heart, Lung, and Blood Institute funded multimodal intervention study. Clin Pliannacol Hier 1992; 51: 581.
    • (1992) Clin Pliannacol Hier , vol.51 , pp. 581
    • Weintraub, M.1
  • 3
    • 13344295079 scopus 로고    scopus 로고
    • Serum immunoreactive-leptin concentrations in normal-weight and obese humans
    • Considine RV, Sinha MK, Heiman ML et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. New Engl J Med 1996; 334: 292-295.
    • (1996) New Engl J Med , vol.334 , pp. 292-295
    • Considine, R.V.1    Sinha, M.K.2    Heiman, M.L.3
  • 4
    • 0028978910 scopus 로고
    • Genetic variation in the beta3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity
    • Clement K, Vaisse C, Manning BS et al. Genetic variation in the beta3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. New Engl J Med 1995; 333: 352-354.
    • (1995) New Engl J Med , vol.333 , pp. 352-354
    • Clement, K.1    Vaisse, C.2    Manning, B.S.3
  • 5
    • 33646856669 scopus 로고
    • Weighing the Options: Criteria for Evaluating Weight-Management Programs
    • Committee to Develop Criteria for Evaluating the Outcomes of Approaches to Prevent and Treat Obesity. Weighing the Options: Criteria for Evaluating Weight-Management Programs. Washington, DC: National Academy Press, 1995: 5.
    • (1995) Washington, DC: National Academy Press , pp. 5
  • 7
    • 0026753155 scopus 로고
    • Beneficial effects of modest weight loss
    • Goldstein DS. Beneficial effects of modest weight loss. Int J Obesity 1992; 16: 397-415.
    • (1992) Int J Obesity , vol.16 , pp. 397-415
    • Goldstein, D.S.1
  • 8
    • 0025808739 scopus 로고
    • The heterogenecity of obesity: Fitting treatments to individual
    • Brownell KD, Wadden TA. The heterogenecity of obesity: fitting treatments to individual. Behav Tlier 1991; 22: 153-177.
    • (1991) Behav Tlier , vol.22 , pp. 153-177
    • Brownell, K.D.1    Wadden, T.A.2
  • 9
    • 0025080094 scopus 로고
    • Long-term effects of dieting on resting metabolic rate in obese outpatients
    • Wadden TA, Foster GD, Letizia KA, Müllen JL. Long-term effects of dieting on resting metabolic rate in obese outpatients. JAMA 1990; 264: 707-711.
    • (1990) JAMA , vol.264 , pp. 707-711
    • Wadden, T.A.1    Foster, G.D.2    Letizia, K.A.3    Müllen, J.L.4
  • 10
    • 0030638144 scopus 로고    scopus 로고
    • Position of the American Dietetic Association on Weight Management
    • The American Dietetic Association. Position of the American Dietetic Association on Weight Management. J Am Dietetic Assoc 1997; 1: 71-74.
    • (1997) J Am Dietetic Assoc , vol.1 , pp. 71-74
  • 11
    • 0026596002 scopus 로고
    • Metabolic consequences of fenfluramine for the control of body weight
    • Levitsky DA, Troiano R. Metabolic consequences of fenfluramine for the control of body weight. AmJ Clin Nutrition 1992; 55: 167S-172S.
    • (1992) AmJ Clin Nutrition , vol.55
    • Levitsky, D.A.1    Troiano, R.2
  • 12
    • 0030593413 scopus 로고    scopus 로고
    • Dexfenfluramine for obesity
    • Editorial Staff. Dexfenfluramine for obesity. Med Letter 1996; 38: 64-65.
    • (1996) Med Letter , vol.38 , pp. 64-65
  • 13
    • 0029799509 scopus 로고    scopus 로고
    • Pharmacotherapy for obesity: Do the benefits outweigh the risks? [editorial]
    • Manson JE, Faich GA. Pharmacotherapy for obesity: Do the benefits outweigh the risks? [editorial]). New EnglJ Med 1996; 335: 659-660.
    • (1996) New EnglJ Med , vol.335 , pp. 659-660
    • Manson, J.E.1    Faich, G.A.2
  • 14
    • 0028295544 scopus 로고
    • Dexfenfluramine reduces cardiovascular risk factors
    • Bremer JM, Russell S, Lintott CJ. Dexfenfluramine reduces cardiovascular risk factors. IntJ Obesity 1994; 18: 199-205.
    • (1994) IntJ Obesity , vol.18 , pp. 199-205
    • Bremer, J.M.1    Russell, S.2    Lintott, C.J.3
  • 15
    • 0026549721 scopus 로고
    • The effects of dexfenfluramine on blood glucose control in patients with type 2 diabetes
    • Willey KA, Molyneaux LM, Overland JE, Yue DK. The effects of dexfenfluramine on blood glucose control in patients with type 2 diabetes. Diabetic Med 1992; 9: 341-343.
    • (1992) Diabetic Med , vol.9 , pp. 341-343
    • Willey, K.A.1    Molyneaux, L.M.2    Overland, J.E.3    Yue, D.K.4
  • 16
    • 0027526493 scopus 로고
    • Dexfenfluramine in type E diabetes: Effect on weight and diabetes control
    • Stewart GO, Stein GR, Davis TM, Findlater P. Dexfenfluramine in type E diabetes: effect on weight and diabetes control. Med J Australia 1993; 158: 167-169.
    • (1993) Med J Australia , vol.158 , pp. 167-169
    • Stewart, G.O.1    Stein, G.R.2    Davis, T.M.3    Findlater, P.4
  • 18
    • 10544235698 scopus 로고    scopus 로고
    • Long-term pharmacotherapy in the management of obesity
    • National Task Force on the Prevention and Treatment of Obesity. Long-term pharmacotherapy in the management of obesity. JAMA 1996; 276: 1907-1915.
    • (1996) JAMA , vol.276 , pp. 1907-1915
  • 19
    • 0028889089 scopus 로고
    • Neuroendocrine abnormalities in human obesity
    • Bjorntorp P. Neuroendocrine abnormalities in human obesity. Metabolism 1995; 44: 38-41.
    • (1995) Metabolism , vol.44 , pp. 38-41
    • Bjorntorp, P.1
  • 20
    • 0021923986 scopus 로고
    • D-fenfluramine selectively suppresses carbohydrate snacking by obese subjects
    • Wurtman JJ, Wurtman RJ, Tsay MS et al. D-fenfluramine selectively suppresses carbohydrate snacking by obese subjects. Int J Eating Disorders 1985; 4: 89-99.
    • (1985) Int J Eating Disorders , vol.4 , pp. 89-99
    • Wurtman, J.J.1    Wurtman, R.J.2    Tsay, M.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.